ACG 2024 Research: Presentation by Evan S. Dellon, MD, MPH

Lead author and professor of medicine in the division of gastroenterology and hepatology and director of the center for esophageal diseases and swallowing at the University of North Carolina School of Medicine, Evan S. Dellon, MD, MPH, presented a new Target RWE study at ACG 2024 titled, “Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort.”

This study delves into a real-world analysis of EoE treatment patterns. We explore the factors associated with patients who do not receive medication, even after diagnosis. Watch Dr. Dellon discuss our latest research findings.